505 COAST BOULEVARD SOUTH, LA JOLLA, CA
CalciMedica Stockholders Approve 2023 Amended Equity Incentive Plan
Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
Annual Report to Security Holders
Board Expansion - Evgeny Zaytsev Appointed as Class I Director
CalciMedica, Inc. Enters First Amendment to Loan Agreement for $10M
Investor Presentation
Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Q2
Q1
Amended Annual Report
FY 2025
Q3
FY 2024
Registration Statement for Securities Offered under a Shelf Registration
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
S-8 POS